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Uptake of purines in Plasmodium falciparum-infected
human erythrocytes is mostly mediated by the
human Equilibrative Nucleoside Transporter and the
human Facilitative Nucleobase Transporter
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Abstract
Background: Plasmodium parasites are unable to synthesize purines de novo and have to salvage them from the
host. Due to this limitation in the parasite, purine transporters have been an area of focus in the search for anti-
malarial drugs. Although the uptake of purines through the human equilibrative nucleoside transporter (hENT1),
the human facilitative nucleobase transporter (hFNT1) and the parasite-induced new permeation pathway (NPP)
has been studied, no information appears to exist on the relative contribution of these three transporters to the
uptake of adenosine and hypoxanthine. Using the appropriate transporter inhibitors, the role of each of these
salvage pathways to the overall purine transport in intraerythrocytic Plasmodium falciparum was systematically
investigated.
Methods: The transport of adenosine, hypoxanthine and adenine into uninfected and P. falciparum-infected
human erythrocytes was investigated in the presence or absence of classical inhibitors of the hFNT1, hENT1 and
NPP. The effective inhibition of the various transporters by the classical inhibitors was verified using appropriate
known substrates. The ability of high concentration of unlabelled substrates to saturate these transporters was also
studied.
Results: Transport of exogenous purine into infected or uninfected erythrocytes occurred primarily through
saturable transporters rather than through the NPP. Hypoxanthine and adenine appeared to enter erythrocytes
mainly through the hFNT1 nucleobase transporter whereas adenosine entered predominantly through the hENT1
nucleoside transporter. The rate of purine uptake was approximately doubled in infected cells compared to
uninfected erythrocytes. In addition, it was found that the rate of adenosine uptake was considerably higher than
the rate of hypoxanthine uptake in infected human red blood cells (RBC). It was also demonstrated that
furosemide inhibited the transport of purine bases through hFNT1.
Conclusion: Collectively, the data obtained in this study clearly show that the endogenous host erythrocyte
transporters hENT1 and hFNT1, rather than the NPP, are the major route of entry of purine into parasitized RBC.
Inhibitors of hENT1 and hFNT1, as well as the NPP, should be considered in the development of anti-malarials
targeted to purine transport.
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Background
Since purine salvage from the host milieu is an impor-
tant physiological requirement for growth and multipli-
cation of Plasmodium falciparum, purine transporters
are regarded as ideal targets for the development of
novel purine-based anti-malarial drugs to combat
malaria [1-3].
Non-infected human erythrocytes take up nucleosides
through the human equilibrative nucleoside transporter
hENT1 [4] and purine bases through the facilitative
nucleobase transporter hFNT1 [5,6]. hENT1, but not
hFNT1, is potently inhibited by 6-[(nitrobenzyl)-thio]9-
b-d-ribofuranosylpurine (NBMPR) [7]. Yet, while
NBMPR completely blocks adenosine uptake in human
erythrocytes, infection with P. falciparum induced an
additional, NBMPR-insensitive, uptake mechanism in
these cells [2,8] and this mechanism does not distin-
guish between the d and l-enantiomers of adenosine [9].
These observations helped define the concept of the
new permeation pathway (NPP), an apparently non-
saturable channel-like system that transports low mole-
cular weight compounds including purines, and is
formed after parasite invasion of erythrocytes [10]. Sev-
eral researchers have described the NPP as exhibiting
functional characteristics of an anion channel; being
selective for Cl- over K+ and blocked by a range of clas-
sical anion channel inhibitors including furosemide and
5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB)
[11-13]. Using the patch-clamp technique, two groups
confirmed the presence and properties of the NPP in P.
falciparum-infected erythrocytes [14,15].
While it is clearly established that the NPP is capable
of mediating adenosine uptake, it is less clear whether
this function is important in terms of its contribution to
the overall purine salvage given the continued presence
of both hENT1 and hFNT1 in parasitized RBC. It is also
unknown whether hypoxanthine, the preferred purine of
P. falciparum [16,17], is a permeant of the NPP. In the
current study we thus investigated the degree to which
the overall purine salvage by intraerythrocytic P. falci-
parum is dependent on the NPP. The transport of ade-
nosine, hypoxanthine and adenine into P. falciparum-
infected and uninfected human erythrocytes was, there-
fore, studied in the presence of selective inhibitors. The
results show that despite the presence of the NPP,
transport of nucleoside and nucleobase into infected
RBC is largely through hENT1 and hFNT1, respectively.
Methods
Transport assays with infected cells were performed
with the standard 3D7 drug-sensitive laboratory clone of
P. falciparum, originally obtained from David Walliker
(School of Biological Sciences, University of Edinburgh,
Edinburgh, Scotland, UK). Human blood and serum
used for Plasmodium culture were obtained from the
Glasgow and West of Scotland Blood Transfusion Ser-
vice. Asexual parasites of P. falciparum were maintained
in continuous culture using slightly modified standard
methods [18]. Briefly, parasites were grown in RPMI
1640 medium supplemented with 5.94 g/l HEPES, 0.21%
NaHCO3 and 10% heat-inactivated normal human
serum at 5% haematocrit. The culture was incubated at
37°C under a gas mixture of 1% O2, 3% CO2 and 96%
N2, and medium was changed daily. Prior to use in
experiments, parasite cultures were synchronized using
a previously described method [19].
Using the method described by the group of Kramer
[20], synchronized cultures of parasitized erythrocytes at
trophozoite stage were enriched for infected cells on iso-
tonic Percoll™ (Amersham Biosciences) gradients (den-
sity 1.090 and osmolality 320 mosm (kg H2O)
-1),
resulting in a suspension with >80% parasitaemia. The
trophozoite-enriched red blood cells harvested were
washed three times with Erythrocyte Medium (140 mM
NaCl, 5 mM KCl, 20 mM Tris/HCl (pH 7.4), 2 mM
MgCl2, and 0.1 mM EDTA) and re-suspended in the
same media for all the experiments performed in this
study. In experiments that compared uptake into unin-
fected erythrocytes with parasitized erythrocytes, ery-
throcytes from the same donor were incubated in
parallel with the infected erythrocyte cultures under the
same conditions and were similarly centrifuged through
Percoll before being used in the assay. Cell concentra-
tions were determined with an improved Neubauer
counting chamber.
All experiments with P. falciparum parasites were car-
ried out using synchronized and Percoll enriched tro-
phozoite-infected human erythrocytes. [2,8-3H]-Adenine
(27 Ci/mmol) used in this study was purchased from
Moravek (USA) whilst [2,8-3H]-adenosine (23 Ci/mmol)
and [8-3H]-hypoxanthine (19 Ci/mmol) were obtained
from Amersham Pharmacia Biotech (UK). Unlabelled
adenine, hypoxanthine, adenosine and uridine of highest
purity were obtained from Sigma. Transport of [3H]-
adenosine, [3H]-adenine and [3H]-hypoxanthine into P.
falciparum-infected erythrocytes and uninfected erythro-
cytes in the presence of NBMPR (Sigma), furosemide
(Sigma), NPPB (Sigma) or 1 mM unlabelled permeant
was determined exactly as previously described [21].
Briefly, equal volumes of a suspension of the cells
(usually at a concentration of 4 × 107 cells/assay) and a
radiolabeled permeant at twice its final concentration
were mixed for predetermined times. Influx of extracel-
lular radiolabeled permeant into the cells was termi-
nated by the addition of 1 ml ice-cold stop solution
followed by a quick spin at 13,000 × g to sediment cells
Quashie et al. Malaria Journal 2010, 9:36
http://www.malariajournal.com/content/9/1/36
Page 2 of 10
through an oil-mix (300 μl of 5 parts dibutylphthalate
(Aldrich): 4 parts dioctyl phthalate (Aldrich), v/v). The
stop solutions used in the experiments in this study
contain dilazep, furosemide, or papaverine (all from
Sigma), to
terminate uptake through hENT1, NPP and hFNT1,
respectively. Cold stop solutions are designed to stop
further uptake of permeant into the cells while the cells
pellet below the oil-mix [5]. All experiments described
in this study were performed in triplicate.
After the uptake of the permeant, the pellets were
retrieved and processed for scintillation counting of
radiolabel incorporated using the method previously
described by Saliba and colleagues [22]. All uptake data
presented in this study are presumed to represent a
“mediated uptake,” defined as the total uptake of the
permeant apart from simple diffusion through the
plasma membrane, which is not a saturable process.
Non-mediated uptake of the respective permeant was
assessed by determining the rate of uptake of the radi-
olabeled permeant in the presence of 1 mM unlabelled
permeant as well as with cells and permeant at 0°C and
subtracted from total uptake. The rate of uptake of the
permeant was obtained from a plot of permeant concen-
tration against time using the Prism 4 (GraphPad) soft-
ware package. Ki values were calculated from the
equation Ki = IC50/(1+ [L/Km]), where L is the permeant
concentration. The Km and Vmax values were obtained
for the transporters using the Michaelis-Menten plot.
Results
Classical inhibitors such as the NPPB, NBMPR and fur-
osemide were chosen for use in this study based on
their published properties and subsequent verification in
preliminary experiments in this study. We tested the
effect of NPPB on the uptake of sorbitol, a well-known
substrate of the NPP [11,23], into infected RBC. The
presence of 300 μM NPPB inhibited [3H]-sorbitol
uptake by over 95% in infected RBC; uninfected RBC,
lacking the NPP, displayed no detectable [3H]-sorbitol
uptake (Figure 1). These findings confirm the inhibitory
effect of NPPB on the NPP [12] and are consistent with
observations reported by Staines and colleagues [24]. A
mean IC50 of 4.5 ± 1.8 μM (n = 3) was determined for
the inhibition of sorbitol uptake by NPPB (Figure 1,
insert).
Nucleoside uptake
Uptake of adenine, hypoxanthine adenosine and uridine
into P. falciparum infected or uninfected RBC in the
presence or absence of NBMPR, furosemide or NPPB
was studied. Uptake of [3H]-adenosine in P. falciparum-
infected and uninfected human erythrocytes was linear
(r2 = 0.93 - 0.99) for at least 10 seconds, allowing the
determination of uptake rates by linear regression over
this interval. [3H]-Adenosine was rapidly taken up by
uninfected human erythrocytes with a rate of 0.032 ±
0.006 pmol(107 cells)-1s-1 with complete inhibition of
uptake in the presence of 1 mM unlabelled permeant
(Figure 2A, B). Uptake of 0.5 μM [3H]-adenosine was
also 95% inhibited by 100 nM NBMPR (Figure 2A), con-
sistent with the well-documented presence of the
NBMPR-sensitive hENT1 adenosine transporter in
human erythrocytes [4,7]. In contrast, adenosine uptake
into human red blood cells (RBC) was not inhibited by
100 μM furosemide (Fig. 2B), an inhibitor of the P. falci-
parum-induced NPP [11]. Uptake of 0.5 μM [3H]-ade-
nosine was faster (0.070 ± 0.005 pmol(107 cells)-1s-1) in
P. falciparum-infected erythrocytes than in uninfected
cells (0.033 ± 0.006 pmol(107 cells)-1s-1), and also
reached a higher level (Figure 2), consistent with a gen-
erally higher level of nutrient uptake in infected cells as
discussed by Kirk and colleagues [10]. This was not the
result of significant levels of transport through the NPP,
however, as adenosine uptake in infected cells was
almost completely inhibited by NBMPR and was fully
saturable (Figure 2). The rate of adenosine uptake in
infected RBC was identical in the presence or absence
of 100 μM furosemide (0.054 ± 0.006 and 0.059 ± 0.003
pmol(107 cells)-1s-1, respectively, for the experiment
shown in Figure 2B).
To demonstrate that the observation made with ade-
nosine is genuine and is not attributable to purine meta-
bolism within the cell, we repeated this assay using
[3H]-uridine in the presence or absence of the NPP inhi-
bitor NPPB; uridine is not metabolized by human ery-
throcytes or by P. falciparum [25-27]. At room
temperature, uptake of 25 μM [3H]-uridine into the cells
was too rapid to allow for accurate uptake rate measure-
ments (Figure 3A) and the experiment was therefore
repeated at 8°C (Figure 3B). At this temperature, uridine
uptake into uninfected and infected erythrocytes in the
absence of NPPB was estimated as 0.33 ± 0.03 pmol(107
cells)-1s-1 and 0.43 ± 0.05 pmol(107 cells)-1s-1, respec-
tively, showing an increase in infected cells as observed
for adenosine uptake (see above), though the increase
was less pronounced in the case of uridine. In unin-
fected cells, 300 μM NPPB did not inhibit the rate of
uridine uptake (0.37 ± 0.03 pmol(107 cells)-1s-1), as
expected for uptake through hENT1. Unexpectedly,
NPPB appeared to increase uridine uptake in P. falci-
parum-infected erythrocytes, displaying a rate of 0.76 ±
0.08 pmol(107 cells)-1s-1. This difference was small but
consistently observed both at 8°C and room temperature
and sometimes also in the uninfected RBC. While no
explanation immediately offers itself for this observation,
it certainly does not indicate a significant contribution
of uridine uptake by the NPP, a conclusion much
strengthened by the near-complete inhibition by 1 mM
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unlabelled uridine (Figure 3A-C). Uridine uptake by
hENT1 displayed a Km value of 177 ± 30 μM in unin-
fected RBC (n = 3; data not shown), consistent with the
published value of 190 ± 12 μM [28], explaining the
residual uptake at 1 mM unlabelled uridine. At 300 μM,
NPPB did not affect hENT1-mediated [3H]-uridine
uptake, but it inhibited this process by 20 - 50% at 1
mM (n = 3) (Figure 3C).
Nucleobase uptake
Uptake of 0.25 μM [3H]-adenine into uninfected RBC
was found to be linear for up to 15 sec (r2 = 0.98) with
a rate of 0.22 ± 0.01 pmol(107 cells)-1s-1and was 93%
inhibited by 1 mM unlabelled adenine (Figure 4A), in
good agreement with previously published results [21].
The Km for [
3H]-adenine in uninfected human erythro-
cytes was determined as 19 ± 1 μM (n = 3; data not
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Figure 1 Sorbitol transport in Plasmodium falciparum-infected and uninfected human erythrocytes in the presence or absence of
NPPB. Uptake of 10 mM [3H]-sorbitol into uninfected erythrocytes (open circles) and into Percoll-enriched Plasmodium falciparum-infected
erythrocytes in the presence (solid triangles) or absence (solid squares) of 300 μM NPPB was determined over a period of five minutes as
indicated. Inset: Inhibition of 10 mM [3H]-sorbitol (expressed as pmol(107 cells)-1s-1) into Percoll-enriched P. falciparum-infected erythrocytes by
various concentrations of NPPB as indicated. All data shown are the average of triplicate determinations. Error bars represent SEM; where not
shown, bars fall within the symbol.
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Figure 2 Adenosine transport in Plasmodium falciparum-infected and uninfected human erythrocytes in the presence or absence of
NBMPR. Uptake of 0.5 μM [3H]-adenosine in Percoll-enriched infected (closed symbols, dashed lines) and uninfected (open symbols, solid lines)
erythrocytes without inhibitor (squares), in the presence of inhibitor (circles) or 1 mM unlabelled adenosine (triangles). A, inhibitor is 0.1 μM
NBMPR. Uptake in both infected and uninfected RBC was fully inhibited by either the presence of 1 mM adenosine or by 0.1 μM NBMPR. B,
inhibitor is 100 μM furosemide. Adenosine uptake was not significantly reduced by 100 μM furosemide, either in infected or uninfected RBC.
Uptake was expressed as pmol(107 cells)-1; experiments shown are representative of four independent experiments and conducted in triplicate;
bars are SEM.
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shown), similar to the values of 13 ± 1 μM [5] and 16 ±
4.5 [21] reported earlier.
The hFNT1 nucleobase transporter is the only route
of uptake for adenine and hypoxanthine in human ery-
throcytes [6,21] and it was next investigated whether
this transporter is inhibited by inhibitors of the NPP.
Like hENT1-mediated [3H]-uridine uptake, hFNT1-
mediated [3H]-adenine uptake was not inhibited by
NPPB at up to 1 mM (n = 3; Figure 4B). However, fur-
osemide clearly inhibited hFNT1 with a Ki value of 9.1
± 1.7 μM (n = 4; Figure 4C). This was surprising as
furosemide is not known to inhibit mammalian purine
transporters. Thus, whilst uptake of 1 μM [3H]-hypox-
anthine by infected RBC over the initial 10 s was 67%
inhibited by 250 μM furosemide, uptake in uninfected
RBC conducted in parallel was similarly inhibited
(63%) (Figure 5A), providing scant evidence for the
involvement of NPP in hypoxanthine uptake. More-
over, NPPB did not inhibit [3H]-hypoxanthine uptake
in P. falciparum-infected human erythrocytes, and the
residual [3H]-hypoxanthine uptake in the presence of 1
mM unlabelled hypoxanthine was not inhibited by the
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Figure 3 Uridine transport in Plasmodium falciparum-infected and uninfected human erythrocytes in the presence or absence of
NPPB. A, B Uptake of 25 μM [3H]-uridine into P. falciparum-infected erythrocytes (closed symbols and dotted lines) and uninfected erythrocytes
(open symbols, solid lines), expressed as pmol(107 cells)-1, was determined for the indicated times, at 22°C (A), or 8°C (B), respectively. Squares, no
inhibitor; circles, 300 μM NPPB; triangles, 1 mM unlabelled uridine. Lines were calculated by linear regression and the results are the average of
duplicate determinations. At 8 pmol(107 cells)-1, the intracellular concentration of uridine is estimated at 10.8 μM, using a published volume of
75 fL per infected erythrocyte [22]; thus, uridine has not reached equilibrium and linear rates of uptake are being measured over the interval of
9 s. C, Transport of 25 μM [3H]-uridine, expressed as pmol(107 cells)-1s-1, in uninfected human erythrocytes in the presence of various
concentrations of NPPB (open circles) or unlabelled uridine (solid squares). Incubation time was 3 s and the experiment shown is representative
of four independent experiments, each conducted in triplicate.
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Figure 4 Adenine transport in uninfected human erythrocyte. A, Uptake of 0.25 μM [3H]-adenine into uninfected human erythrocytes in the
presence (open circles) or absence (solid squares) of 1 mM unlabelled adenine, expressed as pmol(107 cells)-1. Experiment shown is
representative of four independent experiments conducted in triplicate. B and C, Uptake of 1 μM [3H]-adenine, expressed as pmol(107 cells)-1s-1,
by uninfected human erythrocytes over 5 s, in the presence or absence of various concentrations of unlabelled adenine (solid squares), NPPB
(Frame B, open circles) or furosemide (Frame C, open circles). Experiments shown are representative of four independent experiments and
conducted in triplicate. Bars represent SEM.
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further addition of 300 μM NPPB either (Figure 5B). It
was observed, however, that the rate of hypoxanthine
uptake in infected RBC differed substantially from
batch to batch, obtained from different donors. In
some experiments, there did appear to be a level of
inhibition by 300 μM NPPB, but the level of inhibition
by NPPB plus 1 mM hypoxanthine was never more
than with 1 mM hypoxanthine alone (Figure 5B, open
bars) and overall it must be concluded from these
experiments that the NPP contribution to hypox-
anthine uptake is minor and not essential for parasite
survival.
Finally, it was tested whether adenine competitively
inhibits [3H]-hypoxanthine in infected RBC. In both
uninfected and P. falciparum-infected erythrocytes,
hypoxanthine uptake was completely blocked in the pre-
sence of 1 mM adenine. It is thus concluded that hypox-
anthine, like adenosine, is overwhelmingly taken up
through hFNT1 rather than NPP.
Uptake of 1 μM [3H]-hypoxanthine into uninfected
erythrocytes by the human facilitative nucleobase
transporter (hFNT1) was generally 50-60% lower than
in infected cells (see Figures 5A, 6A, B), consistent
with the general upregulation of transport also noted
with uridine and adenosine. Absolute rates varied with
the batch of erythrocytes, thus experiments comparing
rates between infected and uninfected erythrocytes
were always performed in parallel, using the same
batch of RBC, with uninfected treated exactly the same
as the infected cells, including centrifugation through
Percoll.
Discussion
Purines, and in particular hypoxanthine, are essential
nutrients that the intracellular malaria parasite requires
for growth and multiplication [17,29]. Since parasites
are only able to obtain these nutrients from the host
milieu through salvage, availability of detailed informa-
tion of the transporters involved in their uptake is cru-
cial for the development of purine-based anti-malarial
drugs. Much progress has been made in the last few
years in identifying and characterizing purine transpor-
ters on the P. falciparum cell surface [1,30,31], and at
least one of these transporters seems to be essential for
growth at physiological purine concentrations [32].
The data presented in this manuscript clearly show
that hypoxanthine enters P. falciparum-infected human
erythrocytes overwhelmingly through a saturable, ade-
nine-sensitive transport mechanism, which is compatible
with the human FNT1 nucleobase transporter, but not
with the properties reported for NPP [10,11]. Adenosine
similarly enters predominantly through a saturable
transporter, consistent with hENT1. The presence of
these transporters on the plasma membrane of non-
infected RBC has previously been reported [4]. Given
the complexity of nutrient transport in the human ery-
throcyte, especially after Plasmodium invasion, it is
imperative that a systematic approach be employed in
order to obtain a genuine conclusion. Therefore, using
classical transport inhibitors such as NPPB, furosemide
and NBMPR, non-metabolized substrates such as uri-
dine, and competitive inhibitors such as adenine for
hypoxanthine uptake, the various pathways involved in
B
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Figure 5 Hypoxanthine uptake in uninfected and P. falciparum-infected human erythrocytes. A, Uptake of 1 μM [3H]-hypoxanthine into P.
falciparum-infected erythrocytes (closed symbols and dotted lines) and uninfected erythrocytes (open symbols, solid lines), expressed as pmol
(107 cells)-1, was determined for up to 10 s: squares, no inhibitor; circles, 250 μM furosemide; triangles, 1 mM unlabelled hypoxanthine. Lines
were calculated by linear regression and the results are the average of triplicate determinations. B, Bargraph of uptake of 0.5 μM [3H]-
hypoxanthine in P. falciparum-infected human erythrocytes over a 2 s interval, expressed as pmol(107 cells)-1s-1. Bars are: Control, no inhibitor
added; NPPB. 300 μM NPPB; Hypox, 1 mM hypoxanthine added; Both, 300 μM NPPB plus 1 mM hypoxanthine added; Closed bars and open bars
represent identical experiments with two different batches of human erythrocytes, from different donors. Bars are mean and SEM of triplicate
determinations at room temperature.
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purine uptake into P. falciparum-infected RBC were sys-
tematically dissected.
Prior to their use, the selectivity and IC50 values of
these inhibitors was re-assessed to confirm which trans-
porters are blocked and at what concentration. Uptake
of sorbitol, a well-known substrate of the NPP [11,23],
into infected RBC was almost fully blocked by NPPB.
This uptake could not have occurred through any of the
endogenous transporters, as there was no sorbitol
uptake in uninfected erythrocytes. Similarly, it was veri-
fied whether known NPP inhibitors affected transport
through the endogenous nucleoside and nucleobase
transporters. NPPB did not affect either carrier, whereas
furosemide was a good inhibitor of hFNT1, but not of
hENT1. Although the mechanism for the furosemide
effect on hFNT1 was not further investigated, the find-
ing is potentially important, particularly towards efforts
in search of purine-based antiplasmodial compounds, as
similar concentrations of furosemide would inhibit both
the NPP and hFNT1. The furosemide inhibition of [3H]-
hypoxanthine and [3H]-adenine uptake reported here
was clearly not through inhibition of the NPP as it was
equally observed in infected and uninfected RBC. In
view of the above inhibitor profile, it is evident that pur-
ine uptake in infected erythrocytes, being saturable and
NPPB-insensitive, is mostly mediated by the human
transporters hENT1 and hFNT1.
There is no doubt that nucleosides and nucleobases
can enter the infected RBC through the furosemide/
NPPB-sensitive new permeation pathways (NPP). For
example, Gero and co-workers showed residual uptake
of d-adenosine in infected human erythrocytes in the
presence of the hENT1 inhibitor NBMPR [7], estimated
at 20% of the uninhibited uptake rate [8], although this
was not observed in the present study (Figure 2A). Kirk
and colleagues [10] similarly demonstrated the NBMPR-
insensitive, but partly furosemide and NPPB-sensitive,
influx of adenosine and thymidine. However, that study
used a concentration of 1 mM extracellular nucleoside,
whereas the present study used a more physiological
concentration of 0.5 μM. Whilst the higher concentra-
tions were useful to demonstrate that nucleoside uptake
through NPP is possible, the present investigation has
sought to address the question whether the intracellular
parasite is dependent on the NPP for purine uptake at
physiological concentrations, which range from 0.1 - 1
μM for both adenosine and hypoxanthine [33,34].
Hypoxanthine uptake in P. falciparum-infected RBC was
recently demonstrated, at 150 μM, to be ~50% inhibited
by dantrolene, a newly discovered inhibitor of NPP, but
the effect of dantrolene on hFNT1-mediated transport
was not tested [35]. As it is here reported that furose-
mide also inhibits both the hFNT1 and NPP transport
pathways, the possibility of similar action by dantrolene
should not be discounted.
Notwithstanding the above, some of the reports from
the group of Gero reported the NBMPR-insensitive
uptake of d-adenosine at 1 μM [8,36]. They further
showed uptake of l-adenosine and l-thymidine by P. fal-
ciparum-infected human erythrocytes, although these
non-physiological enantiomers were not substrates for
hENT1 [9,36]. Instead, uptake of l-nucleosides uptake
was non-saturable and sensitive to furosemide [9] and
NPPB [36], indicative of NPP. The potential of the NPP
to take up low levels of purines, perhaps indiscrimi-
nately, may be of pharmacological importance, allowing
the entry of toxic enantiomers and analogues selectively
into the infected erythrocytes only.
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Figure 6 Effect of adenine on hypoxanthine uptake into uninfected and P. falciparum-infected human erythrocytes. Uptake of 0.5 μM
[3H]-hypoxanthine, expressed as pmol(107 cells)-1, was determined in (A) uninfected and (B) P. falciparum-infected RBC at room temperature.
Solid squares, no inhibitor control; open circles, 1 mM unlabelled hypoxanthine added; solid down triangles, 1 mM adenine added. The rate of
uninhibited hypoxanthine uptake in infected and uninfected RBC was 0.0086 ± 0.0006 and 0.0045 ± 0.0001 pmol(107 cells)-1s-1, respectively; rates
in the presence of 1 mM adenine and hypoxanthine were not significantly different from zero (P > 0.05; F-test). Experiments were performed in
triplicate; error bars represent SEM.
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Gero and colleagues also observed [2] that nucleoside
transport inhibitors, including NBMPR, dilazep and
dipyridamole all display intrinsic activity against P. falci-
parum in vitro, at concentrations that inhibit hENT1
[7]. This appears to show that inhibition of hENT1
leads to purine starvation of the developing parasite,
which would be consistent with the observation that the
rate of adenosine uptake is considerably higher than the
rate of hypoxanthine uptake in infected RBC. Hypox-
anthine is the preferred purine source for P. falciparum
[17,29], but since adenosine is rapidly converted to
hypoxanthine in the cytosol of the infected erythrocyte
[37], it may be that inhibitors of hENT1 should have at
least a growth-delaying effect on P. falciparum in vivo
and that a combination with an inhibitor of hFNT1
would be lethal. It must be emphasized, however, that
such a strategy would also deprive the uninfected ery-
throcytes of a purine source and that, while erythrocytes
do not need purines for nucleic acid synthesis, their
energy balance would be affected. However, it is likely
that infected erythrocytes will be far more severely
affected as their intracellular purine stores would be
rapidly depleted by the highly efficient P. falciparum
purine salvage system [38]. Yet, it is not certain that the
above hENT1 inhibitors perform their anti-malarial
activity by blocking the human adenosine transporter.
For instance, Carter et al [31] report that the main P.
falciparum nucleoside transporter, PfNT1, is 85% inhib-
ited by 10 μM dipyridamole, although Parker et al [30]
in a similar study did not find PfNT1 sensitive to dipyri-
damole. Furthermore, Gero and colleagues present clear
evidence that NBMPR, in particular, is internalized and
metabolized by the parasites [8]. Thus, while not trans-
ported by hENT1, the transport inhibitors could enter
the Plasmodium-infected cells through NPP, and either
inhibit the parasite’s own purine transporters on its
plasma membrane, or attack an intracellular target.
The data presented in the current manuscript show
that uptake of adenosine in infected erythrocytes was
almost completely inhibited by NBMPR and fully satur-
able - features which are inconsistent with the proper-
ties of the NPP. It may therefore be concluded that the
NPP plays only a minor role in the salvage of this
nucleoside in infected RBC. The observation that the
rate of adenosine uptake in infected RBC was identical
in the presence or absence of 100 μM of the NPP-inhi-
bitor furosemide further supports this conclusion.
Owing to the high rate of adenosine transport in ery-
throcytes, the equilibrative nature of hENT1, and the
rapid metabolism of adenosine inside both infected and
non-infected RBC, it is extremely difficult to measure
true initial rates of [3H]-adenosine transport accurately
in this system [7], and the data presented here refer to
uptake, being the sum of transport and metabolism,
rather than transport. However, the authors believe the
conclusion that influx of adenosine is mediated by
hENT1 rather than NPP is completely justified. To
further validate these observations, the experiment was
repeated using uridine as permeant, which is a substrate
of hENT1, but not metabolized by human erythrocytes
[26] or salvaged by P. falciparum [27]. The results show
that, like adenosine, transport of uridine (25 μM) is
overwhelmingly mediated by hENT1, being saturable
and not inhibitable by NPPB.
This study clearly demonstrated that uptake of the
nucleobases in infected human erythrocytes is also
mainly through the exogenous hFNT1 transporter
despite the presence of the NPP. As reported by Domin
and colleagues, the non-infected human erythrocyte
readily takes up adenine and hypoxanthine by facilitated
diffusion through hFNT1 and, using ice-cold papaverine
to instantly stop transport, it is possible to measure
initial rates of transport over a brief but sufficiently
long period [5]. In Figure 5A, the highest level of
hypoxanthine uptake corresponds to an intracellular
concentration of 0.39 μM, using the estimated volume
of 75 fL for infected human erythrocytes reported by
Saliba and co-workers [22], compared to an extracellu-
lar concentration of 1 μM and had thus not reached
equilibrium. The uptake was clearly saturable and the
response to NPPB was variable, resulting in a small
increase in the uptake rate (Figure 5A) or, no difference,
or a minor inhibition (Figure 5B). In addition, the study
shows that initial rates of transport were completely
inhibited by adenine (Figure 6), which cannot be
explained either in terms of [3H]-hypoxanthine trans-
port through NPP, or through effects on hypoxanthine
metabolism: adenine does not intersect with hypox-
anthine metabolism either in the erythrocyte or inside
the parasite [37,39].
An interesting observation made in the current study
is the apparent increase in the uptake rate of these
nucleosides into infected RBC compared to uninfected
erythrocytes. This was observed consistently for hypox-
anthine, adenosine and uridine. While it is to be
expected that infected RBC will take up more purines
due to greater demand for nucleic acid synthesis from
the intracellular parasite, these observations appear to
reflect increased transport capacity, rather than
increased usage. This is particularly obvious for uridine,
which is not metabolized by Plasmodium. While this
phenomenon has been reported previously for other
nutrients, including tryptophan and choline (reviewed
by Kirk and colleagues) [40], this had not yet been
reported for purine transport across the infected ery-
throcyte membrane. The mechanism by which Plasmo-
dium species increase nutrient uptake by host carriers is
still a subject of intense debate.
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Conclusions
Taken together data presented in this study show that
nucleobases and nucleosides present at low levels in the
host plasma gain entry into the infected erythrocyte pre-
dominantly through equilibrative transporters rather
than the parasite-induced New Permeation Pathways - a
process efficiently driven by the rapid salvage of purines
from the erythrocyte cytosol by the intracellular parasite,
thus maintaining a concentration gradient across the
RBC plasma membrane.
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